Archive for March, 2014 RSS subscribe >

EndoACAB – endoscopic atraumatic coronary artery bypass

A modern minimally invasive approach to treat coronary heart disease: EndoACAB. The UK’s first robotic minimally invasive coronary artery bypass was performed in 2000 at Royal Brompton Hospital. Since then, over 700…

RB&HH launches TB screenings for patients requiring immunosuppressant drugs

Traditionally used to prevent the body from rejecting a transplanted organ, immunosuppressant drugs are also prescribed for patients with autoimmune diseases such as rheumatoid arthritis, severe skin conditions (e.g. psoriasis) and gastrointestinal conditions (e.g. crohn’s disease).  More recently, immunosuppressant…

New partnership to increase presence in the Middle East

Royal Brompton and Harefield Specialist Care recently teamed up with The Royal Marsden and Chelsea and Westminster hospitals to exhibit at Arab Health, the second largest healthcare exhibition in the…

Congenital Heart Disease and Pulmonary Arterial Hypertension

Royal Brompton Hospital has a long tradition of national and international leadership in congenital heart disease, the most common birth defect affecting approximately 1% of infants worldwide.  While children’s lives…

Respiratory Weaning from Mechanical Ventilation: Leading the way for Independent breathing

Professor Polkey, Consultant Physician and Dr Cordingley, Consultant in Intensive Care Medicine, discuss the pitfalls of mechanical ventilation and why a respiratory weaning service may be needed. Q. What is…